1. Home
  2. DYN vs HLMN Comparison

DYN vs HLMN Comparison

Compare DYN & HLMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DYN
  • HLMN
  • Stock Information
  • Founded
  • DYN 1984
  • HLMN 1964
  • Country
  • DYN United States
  • HLMN United States
  • Employees
  • DYN N/A
  • HLMN N/A
  • Industry
  • DYN Medicinal Chemicals and Botanical Products
  • HLMN Industrial Machinery/Components
  • Sector
  • DYN Health Care
  • HLMN Consumer Discretionary
  • Exchange
  • DYN Nasdaq
  • HLMN Nasdaq
  • Market Cap
  • DYN 1.2B
  • HLMN 1.5B
  • IPO Year
  • DYN 2020
  • HLMN N/A
  • Fundamental
  • Price
  • DYN $9.38
  • HLMN $8.21
  • Analyst Decision
  • DYN Strong Buy
  • HLMN Buy
  • Analyst Count
  • DYN 15
  • HLMN 6
  • Target Price
  • DYN $43.07
  • HLMN $10.90
  • AVG Volume (30 Days)
  • DYN 3.3M
  • HLMN 1.8M
  • Earning Date
  • DYN 08-11-2025
  • HLMN 08-05-2025
  • Dividend Yield
  • DYN N/A
  • HLMN N/A
  • EPS Growth
  • DYN N/A
  • HLMN N/A
  • EPS
  • DYN N/A
  • HLMN 0.09
  • Revenue
  • DYN N/A
  • HLMN $1,481,633,000.00
  • Revenue This Year
  • DYN N/A
  • HLMN $6.41
  • Revenue Next Year
  • DYN N/A
  • HLMN $6.57
  • P/E Ratio
  • DYN N/A
  • HLMN $87.52
  • Revenue Growth
  • DYN N/A
  • HLMN 0.31
  • 52 Week Low
  • DYN $6.36
  • HLMN $6.55
  • 52 Week High
  • DYN $47.45
  • HLMN $12.08
  • Technical
  • Relative Strength Index (RSI)
  • DYN 45.89
  • HLMN 62.29
  • Support Level
  • DYN $8.95
  • HLMN $7.79
  • Resistance Level
  • DYN $9.83
  • HLMN $8.32
  • Average True Range (ATR)
  • DYN 0.55
  • HLMN 0.29
  • MACD
  • DYN 0.17
  • HLMN 0.06
  • Stochastic Oscillator
  • DYN 74.58
  • HLMN 88.30

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

About HLMN Hillman Solutions Corp.

Hillman Solutions Corp is a provider of hardware-related products and related merchandising services to retail markets in North America. The company sells its products to hardware stores, home centers, mass merchants, pet supply stores, and other retail outlets. Its product lines include thousands of small parts such as fasteners and related hardware items; threaded rod and metal shapes; keys and accessories; builder's hardware; personal protective equipment, such as gloves and eye-wear; and identification items, such as tags and letters, numbers, and signs. The segments of the company are Hardware and Protective Solutions, which is the key revenue-generating segment; Robotics and Digital Solutions; and Canada. It has a business presence in the U.S., Canada and Mexico.

Share on Social Networks: